NCT03816345 2026-04-13Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONational Cancer Institute (NCI)Phase 1 Recruiting300 enrolled
NCT01931644 2024-04-18At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsSanguine BiosciencesCompleted17,667 enrolled